Molecule Name |
DB00225
|
DrugBank Groups |
Approved
|
Cluster No |
91
|
Smiles |
[Gd]1234567(O=C(NC)CN1(CC(O2)=O)CCN3(CC(O4)=O)CCN5(CC(O6)=O)CC(=O7)NC)
|
Download |
mol2, pdbqt
|
TPSA |
146,82
|
Non-H Atoms |
30
|
Non-C/H Atoms |
14
|
Metal-Atoms |
1
|
Electronegative Atoms |
13
|
Stereo Centers |
2
|
Rotatable Bonds |
0
|
Rings Closures |
7
|
Small Rings |
7
|
Aromatic Rings |
0
|
Aromatic Atoms |
0
|
sp3-Atoms |
17
|
Symmetric atoms |
12
|
cLogS |
3,644
|
MW |
573,659
|
cLogP |
-5,5097
|
HBA |
13
|
HBD |
2
|
Ro5 violations |
2
|
Druglikeness |
2,6218
|
DrugScore |
0,624231792130875
|
Mutagenic |
none
|
Tumorigenic |
none
|
Reproductive Effective |
none
|
Irritant |
none
|
Blood-Brain Barrier |
BBB+
|
Human Intestinal Absorption |
HIA-
|
Caco-2 Permeability |
Caco2-
|
P-glycoprotein Substrate |
Substrate
|
P-glycoprotein Inhibitor |
Non-inhibitor
|
P-glycoprotein Inhibitor 2 |
Non-inhibitor
|
Renal Organic Cation Transporter |
Non-inhibitor
|
Aqueous solubility |
-2,3372
|
Caco-2 Permeability 2 |
0,0056
|
Subcellular localization |
Lysosome
|
CYP450 2C9 Substrate |
Non-substrate
|
CYP450 2D6 Substrate |
Non-substrate
|
CYP450 3A4 Substrate |
Substrate
|
CYP450 1A2 Inhibitor |
Non-inhibitor
|
CYP450 2C9 Inhibitor |
Non-inhibitor
|
CYP450 2D6 Inhibitor |
Non-inhibitor
|
CYP450 2C19 Inhibitor |
Non-inhibitor
|
CYP450 3A4 Inhibitor |
Non-inhibitor
|
CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition 2 |
Non-inhibitor
|
AMES Toxicity |
Non AMES toxic
|
Carcinogens |
Non-carcinogens
|
Fish Toxicity |
High FHMT
|
Fish Toxicity (pLC50, mg/L) |
1,7584
|
Tetrahymena Pyriformis Toxicity |
High TPT
|
Tetrahymena Pyriformis Toxicity (pIGC50, ug/L) |
0,231
|
Honey Bee Toxicity |
Low HBT
|
Biodegradation |
Not ready biodegradable
|
Acute Oral Toxicity |
III
|
Rat Acute Toxicity (LD50, mol/kg) |
2,6344
|
Carcinogenicity (Three-class) |
Non-required
|